Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
Avacc 3 has significant advantages over existing whooping cough vaccines
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
The approval comes soon after Corbevax was given the nod for 12-15-year group
Subscribe To Our Newsletter & Stay Updated
